Cargando…
Pharmaconutrition revisited for critically ill patients with coronavirus disease 2019 (COVID-19): Does selenium have a place?
Coronavirus disease 2019 (COVID-19) is a global pandemic causing one of the biggest challenges for critical care medicine. Mortality from COVID-19 is much greater in elderly men, many of whom succumb to acute respiratory distress syndrome (ARDS) triggered by the viral infection. Because there is no...
Autores principales: | Manzanares, William, Moreira, Eduardo, Hardy, Gil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7457937/ https://www.ncbi.nlm.nih.gov/pubmed/33049573 http://dx.doi.org/10.1016/j.nut.2020.110989 |
Ejemplares similares
-
Current knowledges in pharmaconutrition: “Ketogenics” in pediatric gliomas
por: Cecchi, Nicola, et al.
Publicado: (2023) -
Parenteral fish oil: An adjuvant pharmacotherapy for coronavirus disease 2019?
por: Torrinhas, Raquel S., et al.
Publicado: (2021) -
Predictive value of the prognostic nutritional index for the severity of coronavirus disease 2019
por: Hu, Xiang, et al.
Publicado: (2021) -
An exploratory study of selenium status in healthy individuals and in patients with COVID-19 in a south Indian population: The case for adequate selenium status
por: Majeed, Muhammed, et al.
Publicado: (2021) -
High-dose intravenous vitamin C attenuates hyperinflammation in severe coronavirus disease 2019
por: Xia, Guozhi, et al.
Publicado: (2021)